Kestra Advisory Services LLC Reduces Stock Holdings in Cardinal Health, Inc. $CAH

Kestra Advisory Services LLC trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 12.8% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,659 shares of the company’s stock after selling 2,582 shares during the quarter. Kestra Advisory Services LLC’s holdings in Cardinal Health were worth $3,732,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of CAH. Aventura Private Wealth LLC purchased a new position in Cardinal Health during the 4th quarter valued at $25,000. University of Texas Texas AM Investment Management Co. purchased a new stake in Cardinal Health in the fourth quarter worth about $26,000. Bank of Jackson Hole Trust bought a new position in Cardinal Health during the 4th quarter worth about $27,000. Jones Financial Companies Lllp grew its holdings in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares in the last quarter. Finally, Palladiem LLC purchased a new position in Cardinal Health during the 4th quarter valued at about $28,000. Institutional investors own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on CAH shares. Evercore cut their price target on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Weiss Ratings lowered shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. Morgan Stanley raised their price objective on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. Zacks Research downgraded Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Finally, JPMorgan Chase & Co. dropped their target price on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $249.13.

Cardinal Health Stock Down 0.1%

NYSE:CAH opened at $228.57 on Friday. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $243.21. The stock’s 50-day moving average price is $216.25 and its 200-day moving average price is $213.76. The stock has a market capitalization of $53.53 billion, a PE ratio of 34.95, a price-to-earnings-growth ratio of 1.12 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the company posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts expect that Cardinal Health, Inc. will post 10.77 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were issued a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date was Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is presently 31.50%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.